positive

Apollomics, Inc. Company Operational Continuity Update

October 13, 2025 21:22 ET  | Source: Apollomics Inc. FOSTER CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc.…

2 days ago

Lamborghini SC63 aims to finish on a positive note in IMSA GTP finale at Petit Le Mans

Daniil Kvyat returns to the wheel of the #63 LMDh alongside Grosjean and Mortara at Road AtlantaSant’Agata Bolognese, 7 October…

1 week ago

BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinsons disease

Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in Phase I trial participants Secondary…

1 week ago

Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease

SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral…

4 weeks ago

ICMIs Contact Center Expo 2025 Unveils Keynote Speakers

Event Takes Place October 27-30 in Orlando, FloridaSAN FRANCISCO--(BUSINESS WIRE)--ICMI’s Contact Center Expo, which brings contact center industry professionals together…

4 weeks ago

Red Bali Kratom Launch by Happy Go Leafy Sold Out Within Hours

Glendale, CA, Sept. 15, 2025 (GLOBE NEWSWIRE) -- In an exciting turn of events, Happy Go Leafy announced that its…

1 month ago

Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome

September 11, 2025 09:00 ET  | Source: Nacuity Pharmaceuticals, Inc. NPI-001 shows more than 50% reduction in photoreceptor loss caused…

1 month ago

The National Geographic Society and PepsiCo Launch New Food for Tomorrow Program Focused on Regenerative Agriculture

WASHINGTON, Sept. 4, 2025 /PRNewswire/ -- Today, the National Geographic Society and PepsiCo announced their collaboration to harness the power…

1 month ago

Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine

Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All Prespecified Subgroups Company to…

2 months ago

Water Crisis to Water Security: The Art of Living’s Scalable Model for a Water Positive India

BENGALURU, India, Aug. 26, 2025 /PRNewswire/ -- Water is India's lifeline - and its looming crisis. With 80% of the…

2 months ago